{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigrtc4o2qbdm6xju35y7ruszmls64zu52nngbbbbjzcoihph4jmla",
    "uri": "at://did:plc:7kvric26wmefv463vqxooqsv/app.bsky.feed.post/3mhnmngvnbmt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihyf6kmu5mww7yrfq256awn4mjk527hlzsbwlviwushyumgi5eixm"
    },
    "mimeType": "image/jpeg",
    "size": 116604
  },
  "path": "/news/world/india-drugmakers-to-sell-ozempic-copy-for-14-a-month-as-novo-patent-expires",
  "publishedAt": "2026-03-21T15:15:19.000Z",
  "site": "https://nationalpost.com",
  "tags": [
    "Read More"
  ],
  "textContent": "Indian drugmakers seized on the patent expiry for Novo Nordisk A/S’s blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest overweight population. Read More",
  "title": "India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires",
  "updatedAt": "2026-03-21T15:16:31.000Z"
}